Ginkgo Bioworks & Pfizer Collaborate to Discover RNA-Based Drug Candidates September 29, 2023 US-based biotech company Ginkgo Bioworks has entered into a partnership with multinational pharmaceutical and biotech giant Pfizer to discover RNA-based drug candidates.
AstraZeneca's Rare Disease Unit Buys Pfizer Portfolio September 20, 2023 The global pharma giant AstraZeneca's rare disease unit Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.
Page 1 of 1